Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

35
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
35
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

29
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
29
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

87
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
87
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

168
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shock-press: an Italian national survey investigating the use of vasopressors in cardiac patients experiencing cardio-circulatory shock.

Minerva anestesiologica·2026
Same author

Fibrinogen/Albumin Ratio and Outcome in Adult Cardiac Surgery With Cardiopulmonary Bypass.

Anesthesia and analgesia·2026
Same author

Impact of Delayed Heparin Bridging on Bleeding and Stroke After Left Ventricular Assist Device Implantation.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

The Role of Background Activity Monitoring by Amplitude-Integrated EEG to Predict Short-Term Neurological Outcome in Neonates with Congenital Heart Disease: Insights from a Real-Life Retrospective Cohort.

NeuroSci·2026
Same author

From fast track to ultrafast track extubation in cardiac surgery: a systematic review.

Minerva anestesiologica·2026
Same author

Accounting for squared coherence marginally improves the discriminative power of frequency domain cerebral autoregulation markers in surgical aortic valve replacement patients.

Medical & biological engineering & computing·2026

Related Experiment Video

Updated: Sep 14, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

Ramp-Down/Ramp-Up Protocol for Biventricular Dysfunction Management With ECpella Support.

Benedetta Vitali Rosati1, Camilla Dinale1, Alessandro Barbaria2

  • 1Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

JACC. Case Reports
|July 18, 2025
PubMed
Summary

This study presents a ramp-down/ramp-up protocol for managing severe biventricular dysfunction using venoarterial extracorporeal membrane oxygenation (ECMO) and Impella, standardizing care and minimizing complications.

Keywords:
Impellacardiogenic shockleft ventricular unloadingmechanical circulatory support (MCS)venoarterial extracorporeal membrane oxygenation (V-A ECMO)

More Related Videos

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

437
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Related Experiment Videos

Last Updated: Sep 14, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

437
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Medical Devices

Background:

  • Severe biventricular dysfunction presents complex management challenges.
  • Venoarterial extracorporeal membrane oxygenation (ECMO) and Impella are critical interventions for hemodynamic support.

Observation:

  • A standardized ramp-down/ramp-up protocol is essential for managing patients with biventricular dysfunction on ECMO and Impella.
  • Key monitoring includes pulmonary artery catheter, echocardiography, end-tidal CO2, invasive blood pressure, and blood gases, aiming for mixed venous oxygen saturation >65%.

Findings:

  • The protocol involves stabilization followed by serial evaluations of ventricular function every 12 hours to adjust support.
  • Right ventricular function is assessed by reducing ECMO, while left ventricular function is evaluated by reducing Impella support.
  • Initial low Impella flow may indicate left ventricular edema or right ventricular dysfunction.

Implications:

  • This protocol individualizes cardiovascular support and aims to minimize hemodynamic complications.
  • While not guaranteeing myocardial recovery, the protocol guides weaning or bridging strategies.
  • Standardized care improves outcomes in complex critical cardiac cases.